Search results for: 'Cancer Cell Analysis'

This Frost & Sullivan study covers the class 1 3 transmission replacement aftermarket in North America and forecasts market size from 2023 to 2030. The study analyzes passenger and light-duty vehicle transmission replacement trends in the aftermarket and examines the new, used, rebuilt, and remanufactured product segments. Market forecasts are deri...

30 Sep 2016  |  North America  |  Market Research

Strategic Analysis of the North American Commercial Pumps Market

Robust Building and Construction Activities to Act as Key Driver of Growth in 2016

Infographics

×

This market insight covers the global opportunities for the commercial pumps companies in the North American region. It provides a regional analysis of how economic factors will impact the market. Opportunities in terms of the investment landscape, construction boom, rising focus on green buildings, and the economic recovery of the region has been ...

The report provides an overview of the global vaccine market estimating the market size broken down by different segments. Vaccines, though a sub-set of biologics, have a completely different dynamic. Not only are they largely designed for a healthy cohort but are also exponentially influenced by government actions and policies. While old generatio...

In this study, Frost & Sullivan analyzes the mobility innovation ecosystem by examining automotive and mobility-related patents across the connected, autonomous, shared, and electric (CASE) mobility dimensions.Some relevant details are as follows. • The scope covers North America, with a primary focus on the United States, due to the dep...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

16 Dec 2021  |  North America  |  Market Research

Trends and Growth Opportunities in Module-less (Cell to Pack) Battery Structure

Reduction on Modules Directly Results in Price Reduction by 25 to 30%

Infographics

×

Leading battery manufacturers (e.g., BYD, CATL, and LG Chem) and original equipment manufacturers (OEMs) (e.g.,BYD, Daimler, and VW) are now looking at next-generation battery technology that focuses on module-less battery pack technology, which integrates cells directly into the pack without having to package it into modules. In the module-les...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

Globally, incentives to purchase electric trucks and buses in the form of subsidies, tax cuts, or even penalties related to internal combustion engine (ICE) vehicles can go a long way in making electric vehicles (EVs) attractive to fleets by considerably lowering the acquisition cost. Incentives also give original equipment manufacturers (OEMs) pro...